nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP2D6—Alzheimer's disease	0.169	1	CbGaD
Pazopanib—CYP2D6—Rivastigmine—Alzheimer's disease	0.0542	0.264	CbGbCtD
Pazopanib—CYP2D6—Donepezil—Alzheimer's disease	0.0434	0.211	CbGbCtD
Pazopanib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0345	0.168	CbGbCtD
Pazopanib—CYP2D6—Galantamine—Alzheimer's disease	0.0279	0.136	CbGbCtD
Pazopanib—CYP3A4—Donepezil—Alzheimer's disease	0.0276	0.134	CbGbCtD
Pazopanib—CYP3A4—Galantamine—Alzheimer's disease	0.0178	0.0865	CbGbCtD
Pazopanib—MAP3K9—telencephalon—Alzheimer's disease	0.00274	0.0196	CbGeAlD
Pazopanib—FLT4—blood vessel—Alzheimer's disease	0.00261	0.0187	CbGeAlD
Pazopanib—FGF1—blood vessel—Alzheimer's disease	0.00232	0.0166	CbGeAlD
Pazopanib—TAOK1—forebrain—Alzheimer's disease	0.00224	0.016	CbGeAlD
Pazopanib—TAOK1—telencephalon—Alzheimer's disease	0.00206	0.0147	CbGeAlD
Pazopanib—FLT1—blood vessel—Alzheimer's disease	0.00203	0.0145	CbGeAlD
Pazopanib—FGFR3—embryo—Alzheimer's disease	0.002	0.0143	CbGeAlD
Pazopanib—SH2B3—telencephalon—Alzheimer's disease	0.00194	0.0139	CbGeAlD
Pazopanib—FGFR3—forebrain—Alzheimer's disease	0.00177	0.0126	CbGeAlD
Pazopanib—KDR—blood vessel—Alzheimer's disease	0.00172	0.0123	CbGeAlD
Pazopanib—FGFR3—telencephalon—Alzheimer's disease	0.00162	0.0116	CbGeAlD
Pazopanib—MAP3K9—nervous system—Alzheimer's disease	0.00162	0.0116	CbGeAlD
Pazopanib—MAP3K9—central nervous system—Alzheimer's disease	0.00156	0.0112	CbGeAlD
Pazopanib—FLT4—embryo—Alzheimer's disease	0.00156	0.0111	CbGeAlD
Pazopanib—MAP3K9—cerebellum—Alzheimer's disease	0.00152	0.0109	CbGeAlD
Pazopanib—KIT—blood vessel—Alzheimer's disease	0.00152	0.0109	CbGeAlD
Pazopanib—PDGFRB—blood vessel—Alzheimer's disease	0.00149	0.0106	CbGeAlD
Pazopanib—PI4KB—telencephalon—Alzheimer's disease	0.00144	0.0103	CbGeAlD
Pazopanib—FGF1—embryo—Alzheimer's disease	0.00138	0.0099	CbGeAlD
Pazopanib—FGFR2—embryo—Alzheimer's disease	0.00131	0.00935	CbGeAlD
Pazopanib—PIP4K2C—telencephalon—Alzheimer's disease	0.00126	0.00901	CbGeAlD
Pazopanib—FGFR1—telencephalon—Alzheimer's disease	0.00125	0.00894	CbGeAlD
Pazopanib—MAP3K9—brain—Alzheimer's disease	0.00124	0.00886	CbGeAlD
Pazopanib—FGF1—forebrain—Alzheimer's disease	0.00122	0.00876	CbGeAlD
Pazopanib—TAOK1—nervous system—Alzheimer's disease	0.00122	0.0087	CbGeAlD
Pazopanib—FLT1—embryo—Alzheimer's disease	0.00121	0.00867	CbGeAlD
Pazopanib—MAP3K2—telencephalon—Alzheimer's disease	0.00119	0.00855	CbGeAlD
Pazopanib—TAOK1—central nervous system—Alzheimer's disease	0.00117	0.00838	CbGeAlD
Pazopanib—FGFR2—forebrain—Alzheimer's disease	0.00116	0.00827	CbGeAlD
Pazopanib—SH2B3—nervous system—Alzheimer's disease	0.00115	0.00819	CbGeAlD
Pazopanib—TAOK1—cerebellum—Alzheimer's disease	0.00114	0.00819	CbGeAlD
Pazopanib—PDGFRA—embryo—Alzheimer's disease	0.00114	0.00812	CbGeAlD
Pazopanib—AURKC—nervous system—Alzheimer's disease	0.00113	0.00806	CbGeAlD
Pazopanib—FGF1—telencephalon—Alzheimer's disease	0.00113	0.00805	CbGeAlD
Pazopanib—SH2B3—central nervous system—Alzheimer's disease	0.0011	0.00789	CbGeAlD
Pazopanib—AURKC—central nervous system—Alzheimer's disease	0.00109	0.00776	CbGeAlD
Pazopanib—SH2B3—cerebellum—Alzheimer's disease	0.00108	0.00771	CbGeAlD
Pazopanib—FGFR2—telencephalon—Alzheimer's disease	0.00106	0.0076	CbGeAlD
Pazopanib—EPHB6—forebrain—Alzheimer's disease	0.00106	0.00758	CbGeAlD
Pazopanib—KDR—embryo—Alzheimer's disease	0.00102	0.00732	CbGeAlD
Pazopanib—TAOK3—forebrain—Alzheimer's disease	0.00101	0.00723	CbGeAlD
Pazopanib—PDGFRA—forebrain—Alzheimer's disease	0.001	0.00718	CbGeAlD
Pazopanib—CSF1R—embryo—Alzheimer's disease	0.000999	0.00715	CbGeAlD
Pazopanib—FLT1—telencephalon—Alzheimer's disease	0.000985	0.00705	CbGeAlD
Pazopanib—EPHB6—telencephalon—Alzheimer's disease	0.000974	0.00697	CbGeAlD
Pazopanib—STK16—nervous system—Alzheimer's disease	0.000974	0.00697	CbGeAlD
Pazopanib—LYN—nervous system—Alzheimer's disease	0.000964	0.00689	CbGeAlD
Pazopanib—RIOK2—nervous system—Alzheimer's disease	0.000959	0.00686	CbGeAlD
Pazopanib—FGFR3—nervous system—Alzheimer's disease	0.000959	0.00686	CbGeAlD
Pazopanib—MAP3K19—nervous system—Alzheimer's disease	0.000949	0.00679	CbGeAlD
Pazopanib—BMPR1B—nervous system—Alzheimer's disease	0.000949	0.00679	CbGeAlD
Pazopanib—STK16—central nervous system—Alzheimer's disease	0.000938	0.00671	CbGeAlD
Pazopanib—TAOK1—brain—Alzheimer's disease	0.00093	0.00665	CbGeAlD
Pazopanib—TAOK3—telencephalon—Alzheimer's disease	0.000929	0.00665	CbGeAlD
Pazopanib—LYN—central nervous system—Alzheimer's disease	0.000928	0.00664	CbGeAlD
Pazopanib—PDGFRA—telencephalon—Alzheimer's disease	0.000923	0.0066	CbGeAlD
Pazopanib—FGFR3—central nervous system—Alzheimer's disease	0.000923	0.0066	CbGeAlD
Pazopanib—RIOK2—central nervous system—Alzheimer's disease	0.000923	0.0066	CbGeAlD
Pazopanib—STK16—cerebellum—Alzheimer's disease	0.000916	0.00655	CbGeAlD
Pazopanib—MAP3K19—central nervous system—Alzheimer's disease	0.000914	0.00654	CbGeAlD
Pazopanib—BMPR1B—central nervous system—Alzheimer's disease	0.000914	0.00654	CbGeAlD
Pazopanib—KIT—embryo—Alzheimer's disease	0.000908	0.00649	CbGeAlD
Pazopanib—KDR—forebrain—Alzheimer's disease	0.000906	0.00648	CbGeAlD
Pazopanib—FGFR3—cerebellum—Alzheimer's disease	0.000902	0.00645	CbGeAlD
Pazopanib—RIOK2—cerebellum—Alzheimer's disease	0.000902	0.00645	CbGeAlD
Pazopanib—BMPR1B—cerebellum—Alzheimer's disease	0.000893	0.00639	CbGeAlD
Pazopanib—PDGFRB—embryo—Alzheimer's disease	0.000886	0.00634	CbGeAlD
Pazopanib—CSF1R—forebrain—Alzheimer's disease	0.000884	0.00632	CbGeAlD
Pazopanib—SH2B3—brain—Alzheimer's disease	0.000875	0.00626	CbGeAlD
Pazopanib—AURKC—brain—Alzheimer's disease	0.000862	0.00616	CbGeAlD
Pazopanib—STK36—nervous system—Alzheimer's disease	0.000861	0.00616	CbGeAlD
Pazopanib—PI4KB—nervous system—Alzheimer's disease	0.000848	0.00607	CbGeAlD
Pazopanib—MAP2K5—telencephalon—Alzheimer's disease	0.000833	0.00596	CbGeAlD
Pazopanib—LIMK2—nervous system—Alzheimer's disease	0.000832	0.00595	CbGeAlD
Pazopanib—STK36—central nervous system—Alzheimer's disease	0.000829	0.00593	CbGeAlD
Pazopanib—PI4KB—central nervous system—Alzheimer's disease	0.000816	0.00584	CbGeAlD
Pazopanib—CSF1R—telencephalon—Alzheimer's disease	0.000813	0.00581	CbGeAlD
Pazopanib—STK36—cerebellum—Alzheimer's disease	0.00081	0.0058	CbGeAlD
Pazopanib—LIMK2—central nervous system—Alzheimer's disease	0.000801	0.00573	CbGeAlD
Pazopanib—PI4KB—cerebellum—Alzheimer's disease	0.000798	0.00571	CbGeAlD
Pazopanib—PLK4—brain—Alzheimer's disease	0.000788	0.00564	CbGeAlD
Pazopanib—LIMK2—cerebellum—Alzheimer's disease	0.000783	0.0056	CbGeAlD
Pazopanib—STK16—brain—Alzheimer's disease	0.000744	0.00532	CbGeAlD
Pazopanib—PIP4K2C—nervous system—Alzheimer's disease	0.000744	0.00532	CbGeAlD
Pazopanib—KIT—telencephalon—Alzheimer's disease	0.000738	0.00528	CbGeAlD
Pazopanib—LYN—brain—Alzheimer's disease	0.000737	0.00527	CbGeAlD
Pazopanib—FGFR3—brain—Alzheimer's disease	0.000733	0.00524	CbGeAlD
Pazopanib—RIOK2—brain—Alzheimer's disease	0.000733	0.00524	CbGeAlD
Pazopanib—MAP3K19—brain—Alzheimer's disease	0.000725	0.00519	CbGeAlD
Pazopanib—BMPR1B—brain—Alzheimer's disease	0.000725	0.00519	CbGeAlD
Pazopanib—PDGFRB—telencephalon—Alzheimer's disease	0.000721	0.00516	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—Alzheimer's disease	0.000716	0.00512	CbGeAlD
Pazopanib—MAP3K2—nervous system—Alzheimer's disease	0.000705	0.00504	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—Alzheimer's disease	0.0007	0.00501	CbGeAlD
Pazopanib—FGFR1—cerebellum—Alzheimer's disease	0.000694	0.00497	CbGeAlD
Pazopanib—MAP3K2—central nervous system—Alzheimer's disease	0.000679	0.00486	CbGeAlD
Pazopanib—FGF1—nervous system—Alzheimer's disease	0.000664	0.00475	CbGeAlD
Pazopanib—MAP3K2—cerebellum—Alzheimer's disease	0.000664	0.00475	CbGeAlD
Pazopanib—STK36—brain—Alzheimer's disease	0.000658	0.00471	CbGeAlD
Pazopanib—PI4KB—brain—Alzheimer's disease	0.000648	0.00464	CbGeAlD
Pazopanib—FGF1—central nervous system—Alzheimer's disease	0.00064	0.00458	CbGeAlD
Pazopanib—LIMK2—brain—Alzheimer's disease	0.000636	0.00455	CbGeAlD
Pazopanib—FGFR2—nervous system—Alzheimer's disease	0.000628	0.00449	CbGeAlD
Pazopanib—FGF1—cerebellum—Alzheimer's disease	0.000625	0.00447	CbGeAlD
Pazopanib—FGFR2—central nervous system—Alzheimer's disease	0.000604	0.00432	CbGeAlD
Pazopanib—FGFR2—cerebellum—Alzheimer's disease	0.00059	0.00422	CbGeAlD
Pazopanib—FLT1—nervous system—Alzheimer's disease	0.000582	0.00416	CbGeAlD
Pazopanib—EPHB6—nervous system—Alzheimer's disease	0.000575	0.00411	CbGeAlD
Pazopanib—FLT4—brain—Alzheimer's disease	0.000572	0.00409	CbGeAlD
Pazopanib—PIP4K2C—brain—Alzheimer's disease	0.000569	0.00407	CbGeAlD
Pazopanib—FGFR1—brain—Alzheimer's disease	0.000564	0.00403	CbGeAlD
Pazopanib—FLT1—central nervous system—Alzheimer's disease	0.00056	0.00401	CbGeAlD
Pazopanib—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000555	0.00227	CcSEcCtD
Pazopanib—EPHB6—central nervous system—Alzheimer's disease	0.000554	0.00396	CbGeAlD
Pazopanib—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000553	0.00227	CcSEcCtD
Pazopanib—Dry skin—Rivastigmine—Alzheimer's disease	0.000551	0.00226	CcSEcCtD
Pazopanib—STK10—nervous system—Alzheimer's disease	0.000551	0.00394	CbGeAlD
Pazopanib—Nasopharyngitis—Memantine—Alzheimer's disease	0.000549	0.00225	CcSEcCtD
Pazopanib—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000549	0.00225	CcSEcCtD
Pazopanib—TAOK3—nervous system—Alzheimer's disease	0.000548	0.00392	CbGeAlD
Pazopanib—Angiopathy—Galantamine—Alzheimer's disease	0.000548	0.00224	CcSEcCtD
Pazopanib—FLT1—cerebellum—Alzheimer's disease	0.000547	0.00392	CbGeAlD
Pazopanib—PDGFRA—nervous system—Alzheimer's disease	0.000545	0.0039	CbGeAlD
Pazopanib—Breast disorder—Rivastigmine—Alzheimer's disease	0.000543	0.00222	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000542	0.00222	CcSEcCtD
Pazopanib—EPHB6—cerebellum—Alzheimer's disease	0.000541	0.00387	CbGeAlD
Pazopanib—MAP3K2—brain—Alzheimer's disease	0.000539	0.00386	CbGeAlD
Pazopanib—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000537	0.0022	CcSEcCtD
Pazopanib—STK10—central nervous system—Alzheimer's disease	0.00053	0.00379	CbGeAlD
Pazopanib—Mental disorder—Galantamine—Alzheimer's disease	0.000529	0.00217	CcSEcCtD
Pazopanib—Weight decreased—Donepezil—Alzheimer's disease	0.000529	0.00217	CcSEcCtD
Pazopanib—TAOK3—central nervous system—Alzheimer's disease	0.000528	0.00378	CbGeAlD
Pazopanib—Malnutrition—Galantamine—Alzheimer's disease	0.000525	0.00215	CcSEcCtD
Pazopanib—PDGFRA—central nervous system—Alzheimer's disease	0.000525	0.00375	CbGeAlD
Pazopanib—Infestation—Donepezil—Alzheimer's disease	0.000521	0.00213	CcSEcCtD
Pazopanib—Infestation NOS—Donepezil—Alzheimer's disease	0.000521	0.00213	CcSEcCtD
Pazopanib—Pancreatitis—Memantine—Alzheimer's disease	0.00052	0.00213	CcSEcCtD
Pazopanib—STK10—cerebellum—Alzheimer's disease	0.000518	0.00371	CbGeAlD
Pazopanib—Flatulence—Galantamine—Alzheimer's disease	0.000518	0.00212	CcSEcCtD
Pazopanib—TAOK3—cerebellum—Alzheimer's disease	0.000516	0.00369	CbGeAlD
Pazopanib—Dysgeusia—Galantamine—Alzheimer's disease	0.000515	0.00211	CcSEcCtD
Pazopanib—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000514	0.0021	CcSEcCtD
Pazopanib—PDGFRA—cerebellum—Alzheimer's disease	0.000513	0.00367	CbGeAlD
Pazopanib—Myocardial infarction—Donepezil—Alzheimer's disease	0.000511	0.00209	CcSEcCtD
Pazopanib—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000509	0.00209	CcSEcCtD
Pazopanib—Jaundice—Donepezil—Alzheimer's disease	0.000508	0.00208	CcSEcCtD
Pazopanib—FGF1—brain—Alzheimer's disease	0.000508	0.00363	CbGeAlD
Pazopanib—Muscle spasms—Galantamine—Alzheimer's disease	0.000505	0.00207	CcSEcCtD
Pazopanib—Haematuria—Donepezil—Alzheimer's disease	0.000497	0.00204	CcSEcCtD
Pazopanib—Neutropenia—Memantine—Alzheimer's disease	0.000496	0.00203	CcSEcCtD
Pazopanib—Vision blurred—Galantamine—Alzheimer's disease	0.000495	0.00203	CcSEcCtD
Pazopanib—KDR—nervous system—Alzheimer's disease	0.000492	0.00352	CbGeAlD
Pazopanib—MAP2K5—nervous system—Alzheimer's disease	0.000492	0.00352	CbGeAlD
Pazopanib—Epistaxis—Donepezil—Alzheimer's disease	0.000492	0.00201	CcSEcCtD
Pazopanib—Anaemia—Galantamine—Alzheimer's disease	0.000486	0.00199	CcSEcCtD
Pazopanib—Weight decreased—Memantine—Alzheimer's disease	0.00048	0.00197	CcSEcCtD
Pazopanib—CSF1R—nervous system—Alzheimer's disease	0.00048	0.00343	CbGeAlD
Pazopanib—FGFR2—brain—Alzheimer's disease	0.00048	0.00343	CbGeAlD
Pazopanib—Bradycardia—Donepezil—Alzheimer's disease	0.000476	0.00195	CcSEcCtD
Pazopanib—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000474	0.00194	CcSEcCtD
Pazopanib—KDR—central nervous system—Alzheimer's disease	0.000473	0.00339	CbGeAlD
Pazopanib—MAP2K5—central nervous system—Alzheimer's disease	0.000473	0.00339	CbGeAlD
Pazopanib—Infestation NOS—Memantine—Alzheimer's disease	0.000473	0.00194	CcSEcCtD
Pazopanib—Infestation—Memantine—Alzheimer's disease	0.000473	0.00194	CcSEcCtD
Pazopanib—Syncope—Galantamine—Alzheimer's disease	0.000471	0.00193	CcSEcCtD
Pazopanib—Haemoglobin—Donepezil—Alzheimer's disease	0.00047	0.00193	CcSEcCtD
Pazopanib—Weight decreased—Rivastigmine—Alzheimer's disease	0.00047	0.00192	CcSEcCtD
Pazopanib—Haemorrhage—Donepezil—Alzheimer's disease	0.000468	0.00192	CcSEcCtD
Pazopanib—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000466	0.00191	CcSEcCtD
Pazopanib—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000465	0.00191	CcSEcCtD
Pazopanib—Myocardial infarction—Memantine—Alzheimer's disease	0.000464	0.0019	CcSEcCtD
Pazopanib—Infestation—Rivastigmine—Alzheimer's disease	0.000463	0.0019	CcSEcCtD
Pazopanib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000463	0.0019	CcSEcCtD
Pazopanib—KDR—cerebellum—Alzheimer's disease	0.000463	0.00331	CbGeAlD
Pazopanib—MAP2K5—cerebellum—Alzheimer's disease	0.000463	0.00331	CbGeAlD
Pazopanib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000462	0.00189	CcSEcCtD
Pazopanib—CSF1R—central nervous system—Alzheimer's disease	0.000462	0.0033	CbGeAlD
Pazopanib—Loss of consciousness—Galantamine—Alzheimer's disease	0.000462	0.00189	CcSEcCtD
Pazopanib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000461	0.00189	CcSEcCtD
Pazopanib—Urethral disorder—Donepezil—Alzheimer's disease	0.000459	0.00188	CcSEcCtD
Pazopanib—Cough—Galantamine—Alzheimer's disease	0.000459	0.00188	CcSEcCtD
Pazopanib—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000456	0.00187	CcSEcCtD
Pazopanib—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000454	0.00186	CcSEcCtD
Pazopanib—Hypertension—Galantamine—Alzheimer's disease	0.000454	0.00186	CcSEcCtD
Pazopanib—CSF1R—cerebellum—Alzheimer's disease	0.000452	0.00323	CbGeAlD
Pazopanib—Haematuria—Memantine—Alzheimer's disease	0.000451	0.00185	CcSEcCtD
Pazopanib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000448	0.00183	CcSEcCtD
Pazopanib—Chest pain—Galantamine—Alzheimer's disease	0.000447	0.00183	CcSEcCtD
Pazopanib—Myalgia—Galantamine—Alzheimer's disease	0.000447	0.00183	CcSEcCtD
Pazopanib—Arthralgia—Galantamine—Alzheimer's disease	0.000447	0.00183	CcSEcCtD
Pazopanib—Epistaxis—Memantine—Alzheimer's disease	0.000446	0.00183	CcSEcCtD
Pazopanib—FLT1—brain—Alzheimer's disease	0.000445	0.00318	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000444	0.00182	CcSEcCtD
Pazopanib—Haematuria—Rivastigmine—Alzheimer's disease	0.000441	0.00181	CcSEcCtD
Pazopanib—EPHB6—brain—Alzheimer's disease	0.000439	0.00314	CbGeAlD
Pazopanib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000438	0.00179	CcSEcCtD
Pazopanib—Dry mouth—Galantamine—Alzheimer's disease	0.000438	0.00179	CcSEcCtD
Pazopanib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000437	0.00179	CcSEcCtD
Pazopanib—KIT—nervous system—Alzheimer's disease	0.000436	0.00312	CbGeAlD
Pazopanib—Bradycardia—Memantine—Alzheimer's disease	0.000432	0.00177	CcSEcCtD
Pazopanib—Haemoglobin—Memantine—Alzheimer's disease	0.000427	0.00175	CcSEcCtD
Pazopanib—PDGFRB—nervous system—Alzheimer's disease	0.000426	0.00304	CbGeAlD
Pazopanib—Haemorrhage—Memantine—Alzheimer's disease	0.000425	0.00174	CcSEcCtD
Pazopanib—Bradycardia—Rivastigmine—Alzheimer's disease	0.000423	0.00173	CcSEcCtD
Pazopanib—Hypoaesthesia—Memantine—Alzheimer's disease	0.000423	0.00173	CcSEcCtD
Pazopanib—Shock—Galantamine—Alzheimer's disease	0.000422	0.00173	CcSEcCtD
Pazopanib—STK10—brain—Alzheimer's disease	0.000421	0.00301	CbGeAlD
Pazopanib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000421	0.00172	CcSEcCtD
Pazopanib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00042	0.00172	CcSEcCtD
Pazopanib—Chills—Donepezil—Alzheimer's disease	0.00042	0.00172	CcSEcCtD
Pazopanib—KIT—central nervous system—Alzheimer's disease	0.00042	0.003	CbGeAlD
Pazopanib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000419	0.00172	CcSEcCtD
Pazopanib—TAOK3—brain—Alzheimer's disease	0.000419	0.003	CbGeAlD
Pazopanib—Oedema peripheral—Memantine—Alzheimer's disease	0.000418	0.00171	CcSEcCtD
Pazopanib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000418	0.00171	CcSEcCtD
Pazopanib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000417	0.00171	CcSEcCtD
Pazopanib—PDGFRA—brain—Alzheimer's disease	0.000417	0.00298	CbGeAlD
Pazopanib—Skin disorder—Galantamine—Alzheimer's disease	0.000417	0.00171	CcSEcCtD
Pazopanib—Urethral disorder—Memantine—Alzheimer's disease	0.000416	0.00171	CcSEcCtD
Pazopanib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000416	0.0017	CcSEcCtD
Pazopanib—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000415	0.0017	CcSEcCtD
Pazopanib—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000413	0.00169	CcSEcCtD
Pazopanib—Alopecia—Donepezil—Alzheimer's disease	0.000413	0.00169	CcSEcCtD
Pazopanib—ABCB1—blood vessel—Alzheimer's disease	0.000412	0.00295	CbGeAlD
Pazopanib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00041	0.00168	CcSEcCtD
Pazopanib—KIT—cerebellum—Alzheimer's disease	0.00041	0.00293	CbGeAlD
Pazopanib—Mental disorder—Donepezil—Alzheimer's disease	0.00041	0.00168	CcSEcCtD
Pazopanib—PDGFRB—central nervous system—Alzheimer's disease	0.00041	0.00293	CbGeAlD
Pazopanib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000409	0.00168	CcSEcCtD
Pazopanib—Anorexia—Galantamine—Alzheimer's disease	0.000409	0.00167	CcSEcCtD
Pazopanib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000408	0.00167	CcSEcCtD
Pazopanib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000407	0.00167	CcSEcCtD
Pazopanib—Malnutrition—Donepezil—Alzheimer's disease	0.000407	0.00167	CcSEcCtD
Pazopanib—Erythema—Donepezil—Alzheimer's disease	0.000407	0.00167	CcSEcCtD
Pazopanib—ABCG2—telencephalon—Alzheimer's disease	0.000405	0.0029	CbGeAlD
Pazopanib—Flatulence—Donepezil—Alzheimer's disease	0.000401	0.00164	CcSEcCtD
Pazopanib—PDGFRB—cerebellum—Alzheimer's disease	0.0004	0.00286	CbGeAlD
Pazopanib—Dysgeusia—Donepezil—Alzheimer's disease	0.000399	0.00163	CcSEcCtD
Pazopanib—Eye disorder—Memantine—Alzheimer's disease	0.000397	0.00163	CcSEcCtD
Pazopanib—Cardiac disorder—Memantine—Alzheimer's disease	0.000394	0.00161	CcSEcCtD
Pazopanib—Flushing—Memantine—Alzheimer's disease	0.000394	0.00161	CcSEcCtD
Pazopanib—Muscle spasms—Donepezil—Alzheimer's disease	0.000392	0.0016	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000391	0.0016	CcSEcCtD
Pazopanib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000388	0.00159	CcSEcCtD
Pazopanib—Insomnia—Galantamine—Alzheimer's disease	0.000388	0.00159	CcSEcCtD
Pazopanib—Flushing—Rivastigmine—Alzheimer's disease	0.000386	0.00158	CcSEcCtD
Pazopanib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000386	0.00158	CcSEcCtD
Pazopanib—Angiopathy—Memantine—Alzheimer's disease	0.000385	0.00158	CcSEcCtD
Pazopanib—Paraesthesia—Galantamine—Alzheimer's disease	0.000385	0.00158	CcSEcCtD
Pazopanib—Vision blurred—Donepezil—Alzheimer's disease	0.000384	0.00157	CcSEcCtD
Pazopanib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000383	0.00157	CcSEcCtD
Pazopanib—Somnolence—Galantamine—Alzheimer's disease	0.000381	0.00156	CcSEcCtD
Pazopanib—Chills—Memantine—Alzheimer's disease	0.000381	0.00156	CcSEcCtD
Pazopanib—Dyspepsia—Galantamine—Alzheimer's disease	0.000378	0.00155	CcSEcCtD
Pazopanib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000377	0.00154	CcSEcCtD
Pazopanib—Anaemia—Donepezil—Alzheimer's disease	0.000376	0.00154	CcSEcCtD
Pazopanib—KDR—brain—Alzheimer's disease	0.000376	0.00269	CbGeAlD
Pazopanib—MAP2K5—brain—Alzheimer's disease	0.000376	0.00269	CbGeAlD
Pazopanib—Alopecia—Memantine—Alzheimer's disease	0.000375	0.00154	CcSEcCtD
Pazopanib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000375	0.00153	CcSEcCtD
Pazopanib—Chills—Rivastigmine—Alzheimer's disease	0.000373	0.00153	CcSEcCtD
Pazopanib—Decreased appetite—Galantamine—Alzheimer's disease	0.000373	0.00153	CcSEcCtD
Pazopanib—Mental disorder—Memantine—Alzheimer's disease	0.000372	0.00152	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00037	0.00152	CcSEcCtD
Pazopanib—Malnutrition—Memantine—Alzheimer's disease	0.00037	0.00151	CcSEcCtD
Pazopanib—Fatigue—Galantamine—Alzheimer's disease	0.00037	0.00151	CcSEcCtD
Pazopanib—Alopecia—Rivastigmine—Alzheimer's disease	0.000367	0.0015	CcSEcCtD
Pazopanib—CSF1R—brain—Alzheimer's disease	0.000367	0.00262	CbGeAlD
Pazopanib—Syncope—Donepezil—Alzheimer's disease	0.000365	0.0015	CcSEcCtD
Pazopanib—Flatulence—Memantine—Alzheimer's disease	0.000364	0.00149	CcSEcCtD
Pazopanib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000364	0.00149	CcSEcCtD
Pazopanib—Dysgeusia—Memantine—Alzheimer's disease	0.000362	0.00148	CcSEcCtD
Pazopanib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000362	0.00148	CcSEcCtD
Pazopanib—Erythema—Rivastigmine—Alzheimer's disease	0.000362	0.00148	CcSEcCtD
Pazopanib—Loss of consciousness—Donepezil—Alzheimer's disease	0.000358	0.00147	CcSEcCtD
Pazopanib—Flatulence—Rivastigmine—Alzheimer's disease	0.000356	0.00146	CcSEcCtD
Pazopanib—Cough—Donepezil—Alzheimer's disease	0.000355	0.00146	CcSEcCtD
Pazopanib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000354	0.00145	CcSEcCtD
Pazopanib—Hypertension—Donepezil—Alzheimer's disease	0.000352	0.00144	CcSEcCtD
Pazopanib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000351	0.00144	CcSEcCtD
Pazopanib—Vision blurred—Memantine—Alzheimer's disease	0.000348	0.00143	CcSEcCtD
Pazopanib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000348	0.00142	CcSEcCtD
Pazopanib—Myalgia—Donepezil—Alzheimer's disease	0.000347	0.00142	CcSEcCtD
Pazopanib—Chest pain—Donepezil—Alzheimer's disease	0.000347	0.00142	CcSEcCtD
Pazopanib—Arthralgia—Donepezil—Alzheimer's disease	0.000347	0.00142	CcSEcCtD
Pazopanib—Anaemia—Memantine—Alzheimer's disease	0.000342	0.0014	CcSEcCtD
Pazopanib—Vision blurred—Rivastigmine—Alzheimer's disease	0.000341	0.0014	CcSEcCtD
Pazopanib—Dry mouth—Donepezil—Alzheimer's disease	0.000339	0.00139	CcSEcCtD
Pazopanib—Abdominal pain—Galantamine—Alzheimer's disease	0.000339	0.00139	CcSEcCtD
Pazopanib—Anaemia—Rivastigmine—Alzheimer's disease	0.000334	0.00137	CcSEcCtD
Pazopanib—KIT—brain—Alzheimer's disease	0.000333	0.00238	CbGeAlD
Pazopanib—Oedema—Donepezil—Alzheimer's disease	0.000332	0.00136	CcSEcCtD
Pazopanib—Syncope—Memantine—Alzheimer's disease	0.000332	0.00136	CcSEcCtD
Pazopanib—Leukopenia—Memantine—Alzheimer's disease	0.000331	0.00136	CcSEcCtD
Pazopanib—Infection—Donepezil—Alzheimer's disease	0.00033	0.00135	CcSEcCtD
Pazopanib—Shock—Donepezil—Alzheimer's disease	0.000327	0.00134	CcSEcCtD
Pazopanib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000326	0.00134	CcSEcCtD
Pazopanib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000325	0.00133	CcSEcCtD
Pazopanib—PDGFRB—brain—Alzheimer's disease	0.000325	0.00233	CbGeAlD
Pazopanib—Loss of consciousness—Memantine—Alzheimer's disease	0.000325	0.00133	CcSEcCtD
Pazopanib—Syncope—Rivastigmine—Alzheimer's disease	0.000324	0.00133	CcSEcCtD
Pazopanib—Cough—Memantine—Alzheimer's disease	0.000323	0.00132	CcSEcCtD
Pazopanib—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000321	0.00132	CcSEcCtD
Pazopanib—Hypertension—Memantine—Alzheimer's disease	0.000319	0.00131	CcSEcCtD
Pazopanib—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000318	0.0013	CcSEcCtD
Pazopanib—Anorexia—Donepezil—Alzheimer's disease	0.000317	0.0013	CcSEcCtD
Pazopanib—Cough—Rivastigmine—Alzheimer's disease	0.000316	0.00129	CcSEcCtD
Pazopanib—Arthralgia—Memantine—Alzheimer's disease	0.000315	0.00129	CcSEcCtD
Pazopanib—Myalgia—Memantine—Alzheimer's disease	0.000315	0.00129	CcSEcCtD
Pazopanib—Chest pain—Memantine—Alzheimer's disease	0.000315	0.00129	CcSEcCtD
Pazopanib—Hypertension—Rivastigmine—Alzheimer's disease	0.000312	0.00128	CcSEcCtD
Pazopanib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000308	0.00126	CcSEcCtD
Pazopanib—Myalgia—Rivastigmine—Alzheimer's disease	0.000308	0.00126	CcSEcCtD
Pazopanib—Chest pain—Rivastigmine—Alzheimer's disease	0.000308	0.00126	CcSEcCtD
Pazopanib—Dry mouth—Memantine—Alzheimer's disease	0.000308	0.00126	CcSEcCtD
Pazopanib—Asthenia—Galantamine—Alzheimer's disease	0.000308	0.00126	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000306	0.00125	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000303	0.00124	CcSEcCtD
Pazopanib—CYP2D6—forebrain—Alzheimer's disease	0.000302	0.00216	CbGeAlD
Pazopanib—Oedema—Memantine—Alzheimer's disease	0.000302	0.00124	CcSEcCtD
Pazopanib—Dry mouth—Rivastigmine—Alzheimer's disease	0.000301	0.00123	CcSEcCtD
Pazopanib—Insomnia—Donepezil—Alzheimer's disease	0.000301	0.00123	CcSEcCtD
Pazopanib—Infection—Memantine—Alzheimer's disease	0.0003	0.00123	CcSEcCtD
Pazopanib—Paraesthesia—Donepezil—Alzheimer's disease	0.000298	0.00122	CcSEcCtD
Pazopanib—Shock—Memantine—Alzheimer's disease	0.000297	0.00122	CcSEcCtD
Pazopanib—Dyspnoea—Donepezil—Alzheimer's disease	0.000296	0.00121	CcSEcCtD
Pazopanib—Nervous system disorder—Memantine—Alzheimer's disease	0.000296	0.00121	CcSEcCtD
Pazopanib—Somnolence—Donepezil—Alzheimer's disease	0.000295	0.00121	CcSEcCtD
Pazopanib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000295	0.00121	CcSEcCtD
Pazopanib—Oedema—Rivastigmine—Alzheimer's disease	0.000295	0.00121	CcSEcCtD
Pazopanib—Diarrhoea—Galantamine—Alzheimer's disease	0.000293	0.0012	CcSEcCtD
Pazopanib—Infection—Rivastigmine—Alzheimer's disease	0.000293	0.0012	CcSEcCtD
Pazopanib—Skin disorder—Memantine—Alzheimer's disease	0.000293	0.0012	CcSEcCtD
Pazopanib—Dyspepsia—Donepezil—Alzheimer's disease	0.000293	0.0012	CcSEcCtD
Pazopanib—Hyperhidrosis—Memantine—Alzheimer's disease	0.000292	0.0012	CcSEcCtD
Pazopanib—Shock—Rivastigmine—Alzheimer's disease	0.00029	0.00119	CcSEcCtD
Pazopanib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00029	0.00119	CcSEcCtD
Pazopanib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000289	0.00118	CcSEcCtD
Pazopanib—Decreased appetite—Donepezil—Alzheimer's disease	0.000289	0.00118	CcSEcCtD
Pazopanib—Anorexia—Memantine—Alzheimer's disease	0.000288	0.00118	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000287	0.00118	CcSEcCtD
Pazopanib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000287	0.00117	CcSEcCtD
Pazopanib—Fatigue—Donepezil—Alzheimer's disease	0.000287	0.00117	CcSEcCtD
Pazopanib—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000285	0.00117	CcSEcCtD
Pazopanib—Pain—Donepezil—Alzheimer's disease	0.000284	0.00116	CcSEcCtD
Pazopanib—Dizziness—Galantamine—Alzheimer's disease	0.000284	0.00116	CcSEcCtD
Pazopanib—Anorexia—Rivastigmine—Alzheimer's disease	0.000281	0.00115	CcSEcCtD
Pazopanib—CYP2D6—telencephalon—Alzheimer's disease	0.000278	0.00199	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000275	0.00113	CcSEcCtD
Pazopanib—Insomnia—Memantine—Alzheimer's disease	0.000273	0.00112	CcSEcCtD
Pazopanib—Vomiting—Galantamine—Alzheimer's disease	0.000273	0.00112	CcSEcCtD
Pazopanib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000272	0.00111	CcSEcCtD
Pazopanib—Paraesthesia—Memantine—Alzheimer's disease	0.000271	0.00111	CcSEcCtD
Pazopanib—Rash—Galantamine—Alzheimer's disease	0.00027	0.00111	CcSEcCtD
Pazopanib—Dermatitis—Galantamine—Alzheimer's disease	0.00027	0.00111	CcSEcCtD
Pazopanib—Dyspnoea—Memantine—Alzheimer's disease	0.000269	0.0011	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000269	0.0011	CcSEcCtD
Pazopanib—Headache—Galantamine—Alzheimer's disease	0.000269	0.0011	CcSEcCtD
Pazopanib—Somnolence—Memantine—Alzheimer's disease	0.000268	0.0011	CcSEcCtD
Pazopanib—Insomnia—Rivastigmine—Alzheimer's disease	0.000267	0.00109	CcSEcCtD
Pazopanib—Dyspepsia—Memantine—Alzheimer's disease	0.000266	0.00109	CcSEcCtD
Pazopanib—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000265	0.00109	CcSEcCtD
Pazopanib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000263	0.00108	CcSEcCtD
Pazopanib—Abdominal pain—Donepezil—Alzheimer's disease	0.000263	0.00108	CcSEcCtD
Pazopanib—Somnolence—Rivastigmine—Alzheimer's disease	0.000262	0.00108	CcSEcCtD
Pazopanib—Decreased appetite—Memantine—Alzheimer's disease	0.000262	0.00107	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000261	0.00107	CcSEcCtD
Pazopanib—Fatigue—Memantine—Alzheimer's disease	0.00026	0.00107	CcSEcCtD
Pazopanib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00026	0.00106	CcSEcCtD
Pazopanib—Pain—Memantine—Alzheimer's disease	0.000258	0.00106	CcSEcCtD
Pazopanib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000257	0.00105	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000255	0.00104	CcSEcCtD
Pazopanib—Nausea—Galantamine—Alzheimer's disease	0.000255	0.00104	CcSEcCtD
Pazopanib—Fatigue—Rivastigmine—Alzheimer's disease	0.000255	0.00104	CcSEcCtD
Pazopanib—Pain—Rivastigmine—Alzheimer's disease	0.000252	0.00103	CcSEcCtD
Pazopanib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000247	0.00101	CcSEcCtD
Pazopanib—ABCB1—embryo—Alzheimer's disease	0.000246	0.00176	CbGeAlD
Pazopanib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000241	0.000989	CcSEcCtD
Pazopanib—Abdominal pain—Memantine—Alzheimer's disease	0.000239	0.000977	CcSEcCtD
Pazopanib—Asthenia—Donepezil—Alzheimer's disease	0.000238	0.000977	CcSEcCtD
Pazopanib—Pruritus—Donepezil—Alzheimer's disease	0.000235	0.000963	CcSEcCtD
Pazopanib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000233	0.000956	CcSEcCtD
Pazopanib—Diarrhoea—Donepezil—Alzheimer's disease	0.000227	0.000932	CcSEcCtD
Pazopanib—ABCG2—cerebellum—Alzheimer's disease	0.000225	0.00161	CbGeAlD
Pazopanib—Dizziness—Donepezil—Alzheimer's disease	0.00022	0.0009	CcSEcCtD
Pazopanib—ABCB1—forebrain—Alzheimer's disease	0.000217	0.00155	CbGeAlD
Pazopanib—Asthenia—Memantine—Alzheimer's disease	0.000217	0.000887	CcSEcCtD
Pazopanib—Pruritus—Memantine—Alzheimer's disease	0.000214	0.000875	CcSEcCtD
Pazopanib—Asthenia—Rivastigmine—Alzheimer's disease	0.000212	0.000868	CcSEcCtD
Pazopanib—Vomiting—Donepezil—Alzheimer's disease	0.000211	0.000866	CcSEcCtD
Pazopanib—Rash—Donepezil—Alzheimer's disease	0.00021	0.000858	CcSEcCtD
Pazopanib—Dermatitis—Donepezil—Alzheimer's disease	0.000209	0.000858	CcSEcCtD
Pazopanib—Pruritus—Rivastigmine—Alzheimer's disease	0.000209	0.000856	CcSEcCtD
Pazopanib—Headache—Donepezil—Alzheimer's disease	0.000208	0.000853	CcSEcCtD
Pazopanib—Diarrhoea—Memantine—Alzheimer's disease	0.000206	0.000846	CcSEcCtD
Pazopanib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000202	0.000827	CcSEcCtD
Pazopanib—ABCB1—telencephalon—Alzheimer's disease	0.0002	0.00143	CbGeAlD
Pazopanib—Dizziness—Memantine—Alzheimer's disease	0.0002	0.000818	CcSEcCtD
Pazopanib—Nausea—Donepezil—Alzheimer's disease	0.000197	0.000809	CcSEcCtD
Pazopanib—Dizziness—Rivastigmine—Alzheimer's disease	0.000195	0.0008	CcSEcCtD
Pazopanib—Vomiting—Memantine—Alzheimer's disease	0.000192	0.000786	CcSEcCtD
Pazopanib—Rash—Memantine—Alzheimer's disease	0.00019	0.000779	CcSEcCtD
Pazopanib—Dermatitis—Memantine—Alzheimer's disease	0.00019	0.000779	CcSEcCtD
Pazopanib—Headache—Memantine—Alzheimer's disease	0.000189	0.000774	CcSEcCtD
Pazopanib—CYP2C8—brain—Alzheimer's disease	0.000188	0.00135	CbGeAlD
Pazopanib—Vomiting—Rivastigmine—Alzheimer's disease	0.000188	0.000769	CcSEcCtD
Pazopanib—Rash—Rivastigmine—Alzheimer's disease	0.000186	0.000763	CcSEcCtD
Pazopanib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000186	0.000762	CcSEcCtD
Pazopanib—Headache—Rivastigmine—Alzheimer's disease	0.000185	0.000758	CcSEcCtD
Pazopanib—ABCG2—brain—Alzheimer's disease	0.000183	0.00131	CbGeAlD
Pazopanib—Nausea—Memantine—Alzheimer's disease	0.000179	0.000734	CcSEcCtD
Pazopanib—Nausea—Rivastigmine—Alzheimer's disease	0.000175	0.000718	CcSEcCtD
Pazopanib—CYP3A4—nervous system—Alzheimer's disease	0.000167	0.00119	CbGeAlD
Pazopanib—CYP2D6—nervous system—Alzheimer's disease	0.000164	0.00117	CbGeAlD
Pazopanib—CYP3A4—central nervous system—Alzheimer's disease	0.00016	0.00115	CbGeAlD
Pazopanib—CYP2D6—central nervous system—Alzheimer's disease	0.000158	0.00113	CbGeAlD
Pazopanib—CYP2D6—cerebellum—Alzheimer's disease	0.000154	0.0011	CbGeAlD
Pazopanib—CYP2D6—brain—Alzheimer's disease	0.000125	0.000896	CbGeAlD
Pazopanib—ABCB1—nervous system—Alzheimer's disease	0.000118	0.000844	CbGeAlD
Pazopanib—ABCB1—central nervous system—Alzheimer's disease	0.000114	0.000812	CbGeAlD
Pazopanib—ABCB1—cerebellum—Alzheimer's disease	0.000111	0.000794	CbGeAlD
Pazopanib—ABCB1—brain—Alzheimer's disease	9.02e-05	0.000645	CbGeAlD
Pazopanib—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	3.53e-06	1.46e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	3.52e-06	1.46e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—GSK3B—Alzheimer's disease	3.49e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—Alzheimer's disease	3.47e-06	1.44e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TGFB1—Alzheimer's disease	3.46e-06	1.43e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—AKT1—Alzheimer's disease	3.46e-06	1.43e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CREB1—Alzheimer's disease	3.46e-06	1.43e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS3—Alzheimer's disease	3.46e-06	1.43e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—INS—Alzheimer's disease	3.45e-06	1.43e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—INS—Alzheimer's disease	3.44e-06	1.42e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKT1—Alzheimer's disease	3.44e-06	1.42e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—Alzheimer's disease	3.41e-06	1.41e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—GSK3B—Alzheimer's disease	3.41e-06	1.41e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.41e-06	1.41e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.41e-06	1.41e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—Alzheimer's disease	3.4e-06	1.41e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MAPK8—Alzheimer's disease	3.39e-06	1.4e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CREB1—Alzheimer's disease	3.38e-06	1.4e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—Alzheimer's disease	3.38e-06	1.4e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—Alzheimer's disease	3.37e-06	1.39e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—INS—Alzheimer's disease	3.37e-06	1.39e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.36e-06	1.39e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—Alzheimer's disease	3.36e-06	1.39e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—Alzheimer's disease	3.35e-06	1.39e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—Alzheimer's disease	3.35e-06	1.38e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—Alzheimer's disease	3.34e-06	1.38e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IGF1—Alzheimer's disease	3.33e-06	1.37e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—Alzheimer's disease	3.31e-06	1.37e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—Alzheimer's disease	3.3e-06	1.37e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—Alzheimer's disease	3.28e-06	1.36e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—AKT1—Alzheimer's disease	3.28e-06	1.36e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PPARG—Alzheimer's disease	3.26e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IGF1—Alzheimer's disease	3.26e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CALM1—Alzheimer's disease	3.24e-06	1.34e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEP—Alzheimer's disease	3.23e-06	1.34e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—Alzheimer's disease	3.23e-06	1.34e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—Alzheimer's disease	3.2e-06	1.32e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CAV1—Alzheimer's disease	3.2e-06	1.32e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—INS—Alzheimer's disease	3.2e-06	1.32e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—Alzheimer's disease	3.18e-06	1.32e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.17e-06	1.31e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.17e-06	1.31e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—Alzheimer's disease	3.17e-06	1.31e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—Alzheimer's disease	3.16e-06	1.31e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—Alzheimer's disease	3.16e-06	1.31e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.16e-06	1.31e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKT1—Alzheimer's disease	3.15e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—Alzheimer's disease	3.13e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—Alzheimer's disease	3.09e-06	1.28e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—Alzheimer's disease	3.09e-06	1.28e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—AKT1—Alzheimer's disease	3.09e-06	1.28e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ESR1—Alzheimer's disease	3.08e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.08e-06	1.27e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.08e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.07e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.07e-06	1.27e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CASP3—Alzheimer's disease	3.06e-06	1.26e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.05e-06	1.26e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—F2—Alzheimer's disease	3.05e-06	1.26e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3.04e-06	1.26e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	3.03e-06	1.25e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	3.03e-06	1.25e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—Alzheimer's disease	3.02e-06	1.25e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—Alzheimer's disease	3.01e-06	1.25e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—Alzheimer's disease	3.01e-06	1.25e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CASP3—Alzheimer's disease	3e-06	1.24e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.99e-06	1.24e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOTCH1—Alzheimer's disease	2.98e-06	1.23e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—Alzheimer's disease	2.95e-06	1.22e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—Alzheimer's disease	2.95e-06	1.22e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.94e-06	1.22e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK8—Alzheimer's disease	2.92e-06	1.21e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.9e-06	1.2e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.89e-06	1.19e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.89e-06	1.19e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—Alzheimer's disease	2.88e-06	1.19e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—Alzheimer's disease	2.86e-06	1.18e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—Alzheimer's disease	2.85e-06	1.18e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CASP3—Alzheimer's disease	2.85e-06	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—Alzheimer's disease	2.85e-06	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CASP3—Alzheimer's disease	2.84e-06	1.17e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—Alzheimer's disease	2.84e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.83e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.83e-06	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK8—Alzheimer's disease	2.81e-06	1.16e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—Alzheimer's disease	2.8e-06	1.16e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—GSK3B—Alzheimer's disease	2.8e-06	1.16e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CREB1—Alzheimer's disease	2.77e-06	1.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—Alzheimer's disease	2.77e-06	1.15e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—LPL—Alzheimer's disease	2.77e-06	1.15e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	2.77e-06	1.14e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—INS—Alzheimer's disease	2.76e-06	1.14e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK8—Alzheimer's disease	2.76e-06	1.14e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.73e-06	1.13e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—Alzheimer's disease	2.72e-06	1.13e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—Alzheimer's disease	2.71e-06	1.12e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.68e-06	1.11e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IGF1—Alzheimer's disease	2.67e-06	1.1e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.65e-06	1.1e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.64e-06	1.09e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK8—Alzheimer's disease	2.62e-06	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK8—Alzheimer's disease	2.61e-06	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—Alzheimer's disease	2.61e-06	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—Alzheimer's disease	2.59e-06	1.07e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—Alzheimer's disease	2.59e-06	1.07e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—Alzheimer's disease	2.58e-06	1.07e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	2.56e-06	1.06e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—Alzheimer's disease	2.56e-06	1.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CASP3—Alzheimer's disease	2.56e-06	1.06e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—Alzheimer's disease	2.56e-06	1.06e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—Alzheimer's disease	2.55e-06	1.05e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	2.55e-06	1.05e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.53e-06	1.05e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—Alzheimer's disease	2.52e-06	1.04e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—Alzheimer's disease	2.51e-06	1.04e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CASP3—Alzheimer's disease	2.51e-06	1.04e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.5e-06	1.03e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.49e-06	1.03e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.49e-06	1.03e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.48e-06	1.03e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—Alzheimer's disease	2.48e-06	1.03e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.46e-06	1.02e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—Alzheimer's disease	2.42e-06	1e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—Alzheimer's disease	2.42e-06	9.99e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—LPL—Alzheimer's disease	2.41e-06	9.98e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—Alzheimer's disease	2.41e-06	9.97e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—Alzheimer's disease	2.41e-06	9.95e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—Alzheimer's disease	2.39e-06	9.87e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—Alzheimer's disease	2.39e-06	9.86e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—Alzheimer's disease	2.38e-06	9.84e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—Alzheimer's disease	2.38e-06	9.84e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—Alzheimer's disease	2.38e-06	9.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.38e-06	9.83e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—Alzheimer's disease	2.37e-06	9.79e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—Alzheimer's disease	2.36e-06	9.77e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK8—Alzheimer's disease	2.35e-06	9.73e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.35e-06	9.72e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—Alzheimer's disease	2.34e-06	9.67e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	2.33e-06	9.64e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.33e-06	9.63e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—Alzheimer's disease	2.32e-06	9.61e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.32e-06	9.6e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—Alzheimer's disease	2.32e-06	9.59e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK8—Alzheimer's disease	2.3e-06	9.52e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.3e-06	9.51e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—Alzheimer's disease	2.28e-06	9.45e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—Alzheimer's disease	2.27e-06	9.41e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.27e-06	9.4e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—Alzheimer's disease	2.27e-06	9.39e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.23e-06	9.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.23e-06	9.21e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—Alzheimer's disease	2.22e-06	9.17e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—Alzheimer's disease	2.21e-06	9.15e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—Alzheimer's disease	2.2e-06	9.11e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—Alzheimer's disease	2.2e-06	9.08e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.19e-06	9.04e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.17e-06	8.98e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—Alzheimer's disease	2.17e-06	8.98e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—Alzheimer's disease	2.17e-06	8.96e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	2.15e-06	8.89e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—Alzheimer's disease	2.15e-06	8.87e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—Alzheimer's disease	2.14e-06	8.86e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—Alzheimer's disease	2.13e-06	8.79e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.12e-06	8.75e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.11e-06	8.71e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—Alzheimer's disease	2.1e-06	8.68e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—Alzheimer's disease	2.1e-06	8.67e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.07e-06	8.57e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CASP3—Alzheimer's disease	2.05e-06	8.49e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.05e-06	8.47e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.03e-06	8.39e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—Alzheimer's disease	2.02e-06	8.36e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.02e-06	8.36e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAV1—Alzheimer's disease	2e-06	8.29e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—Alzheimer's disease	2e-06	8.27e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—Alzheimer's disease	1.99e-06	8.24e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—INS—Alzheimer's disease	1.98e-06	8.2e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—Alzheimer's disease	1.98e-06	8.18e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—Alzheimer's disease	1.96e-06	8.1e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.95e-06	8.08e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—Alzheimer's disease	1.95e-06	8.07e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.93e-06	7.97e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—Alzheimer's disease	1.92e-06	7.96e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.91e-06	7.91e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.91e-06	7.88e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.89e-06	7.83e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.89e-06	7.81e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK8—Alzheimer's disease	1.89e-06	7.81e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—Alzheimer's disease	1.86e-06	7.71e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—Alzheimer's disease	1.83e-06	7.55e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—Alzheimer's disease	1.82e-06	7.53e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—Alzheimer's disease	1.79e-06	7.42e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.76e-06	7.28e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—Alzheimer's disease	1.76e-06	7.28e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—Alzheimer's disease	1.74e-06	7.21e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.74e-06	7.19e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	7.17e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—INS—Alzheimer's disease	1.73e-06	7.14e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—Alzheimer's disease	1.72e-06	7.12e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—Alzheimer's disease	1.72e-06	7.11e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—Alzheimer's disease	1.67e-06	6.91e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—Alzheimer's disease	1.67e-06	6.89e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.66e-06	6.86e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—Alzheimer's disease	1.65e-06	6.84e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—Alzheimer's disease	1.64e-06	6.79e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.63e-06	6.75e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—INS—Alzheimer's disease	1.63e-06	6.73e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.63e-06	6.72e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—Alzheimer's disease	1.63e-06	6.72e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.62e-06	6.7e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.61e-06	6.68e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—Alzheimer's disease	1.61e-06	6.64e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.6e-06	6.62e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—Alzheimer's disease	1.6e-06	6.61e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.59e-06	6.58e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—Alzheimer's disease	1.59e-06	6.57e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—Alzheimer's disease	1.54e-06	6.38e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—Alzheimer's disease	1.54e-06	6.36e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—Alzheimer's disease	1.52e-06	6.28e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.52e-06	6.27e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—Alzheimer's disease	1.5e-06	6.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.49e-06	6.15e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—Alzheimer's disease	1.47e-06	6.08e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.43e-06	5.9e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.41e-06	5.82e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	1.39e-06	5.75e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.39e-06	5.73e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—Alzheimer's disease	1.39e-06	5.73e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INS—Alzheimer's disease	1.38e-06	5.7e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—Alzheimer's disease	1.36e-06	5.61e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.34e-06	5.53e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—Alzheimer's disease	1.32e-06	5.45e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.31e-06	5.4e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—Alzheimer's disease	1.29e-06	5.33e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.25e-06	5.17e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.25e-06	5.15e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.23e-06	5.11e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.21e-06	5e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—Alzheimer's disease	1.21e-06	4.98e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—Alzheimer's disease	1.11e-06	4.6e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	4.57e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.09e-06	4.49e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INS—Alzheimer's disease	1.06e-06	4.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.34e-07	3.86e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.54e-07	3.53e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—Alzheimer's disease	8e-07	3.31e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—Alzheimer's disease	6.97e-07	2.88e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.56e-07	2.71e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.56e-07	2.3e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.29e-07	1.77e-06	CbGpPWpGaD
